date:Mar 21, 2013
ed Illumina's offer, saying it doubted the proposed deal would win approval from US regulators.
By acquiring Complete Genomics' technology, which was found in studies to be both effective and practical, BGI-Shenzhen gains a little leverage over other vendors, Bloomberg News quoted Schenkel as saying. It gives them more of a presence in the services industry and gives them more access to this technology and makes it more of an in-house technology.
Genetic Engineering and Biotechnology News note